FDA Approves Aimmune's (AIMT) Palforzia, Stock Up 17% In After-Hours

The FDA has approved Aimmune Therapeutics Inc.'s (AIMT) Palforzia for the treatment of peanut allergy in patients aged 4 through 17 years.

from RTT - Biotech https://ift.tt/391pXXJ
via IFTTT